Study shows vaccines cut long COVID risk, especially for those with preexisting conditions

FHS
June 19, 2024
3:24 am

A study in JAMA Network Open found that women and individuals with preexisting cardiovascular conditions are more likely to suffer from long COVID, but vaccinations, especially multiple doses, significantly reduce this risk.

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for Squamous Non-Small Cell Lung Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

April 19, 2024

Surgeons to get a high-tech assistant: Smartphone app for assessing liver surgery risks

Researchers developed a multivariable model to predict clinically relevant posthepatectomy liver failure grade B and C, grade C, and 90-day mortality prediction.

November 6, 2023

CureVac Appoints International Financial Expert Michael Brosnan to Supervisory Board – Biotech Investments

Issuer: CureVac / Key word(s): Personnel 20.06.2023 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Appoints International Financial

June 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.